Pyxis Oncology price target raised to $8.00 from $7.00 by HC Wainwright
HC Wainwright & Co. raised its price target on Pyxis Oncology to $8.00 from $7.00. The firm maintained a Buy rating, per the TradingView News item relayed by Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.